Current Oncology MDPI

📢 Current Oncology was awarded an increased Impact Factor of 2.8 in the 2023 Journal Citation Reports™ released by Clarivate in June 2024. ⬆️ The ranking of Current Oncology has been upgraded from Q3 to Q2 (157 out of 322 titles) in the "Oncology" category! 👉 Welcome to read more details here: https://brnw.ch/21wKWm0

🔥 #TopCited #Review "The Clinical Impact of Neoadjuvant Endocrine Treatment on Luminal-like Breast Cancers and Its Prognostic Significance: Results from a Single-Institution Prospective Cohort Study" 👏 by Covadonga Martí et al. ⏩ Read more here: https://lnkd.in/g-TbUh-3

🚨 Call for Papers!🚨 ✨ We invite researchers and clinicians to submit to our upcoming Special Issue: "Estrogen-Receptor Low Positive (ER-Low) Breast Cancer: A New (or Old?) World to Discover." 👉 https://lnkd.in/gE-AumVe This Special Issue, led by Guest Editors Dr. Eleonora Lai and Prof. Dr. Gavino Faa, focuses on the biology, clinical implications, and treatment advancements for #ERlow #BreastCancer — a subtype now under increased scrutiny due to its similarity to triple-negative breast cancer. 🔍 We welcome submissions of original research, reviews and clinical studies to help drive progress in understanding and managing this complex subtype. 🔑 Topics include: Treatment Implications Endocrine Therapy Immunotherapy Chemotherapy Translational & Clinical Research #BreastCancer #Oncology #ERlow #CancerResearch #ClinicalResearch #TranslationalResearch

📍 National Breast Cancer Awareness Month is an annual campaign that takes place in October to increase awareness of this disease. 🔗 Check out our latest research in this field here: https://brnw.ch/21wOboZ

🔥 #TopCited #Review "Slip, Slop, Slap, Slide, Seek and Sport: A Systematic Scoping Review of Sun Protection in Sport in Australasia" 👏 by Sarah K. Morton and Simone L. Harrison ⏩ Read more here: https://lnkd.in/gM-TC8VA

🔥 #TopCited #Review "Autophagy Agents in Clinical Trials for Cancer Therapy: A Brief Review" 👏 by Samiha M. et al. ⏩ Read more here: https://lnkd.in/gDp85fJc

🔥 #TopCited #Review "Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems" 👏 by George Doumat et al. ⏩ Read more here: https://lnkd.in/egQFwSUC

🔥 #TopCited #Review "Immune Checkpoint Inhibitors in Cancer Therapy" 👏 by Yavar Shiravand et al. ⏩ Read more here: https://lnkd.in/g9MF6Sme

We have had an incredible time over the past two days, engaging with experts, sharing knowledge, and connecting with passionate professionals in the field of nuclear medicine. 🚨 But it is not over yet! We are here at EANM'24 (#Y24) until the end of the day 🚨 Do not miss your chance to visit us, share your thoughts, and explore collaboration opportunities. Neurology International MDPI Journal of Clinical Medicine (JCM) MDPI Cancers MDPI Medicina MDPI Children MDPI Sci MDPI Current Oncology MDPI #EANM24 #NuclearMedicine #Congress #ScientificCommunity #Diagnostics

🔥 #TopCited #Review "Impact of Regulatory Approval Status on CADTH Reimbursement of Oncology Drugs and Role of Real-World Evidence on Conditional Approvals from 2019 to 2021" 👏 by Catherine Lau and George Dranitsaris ⏩ Read more here: https://lnkd.in/gb3XhGWz